A Method of Isolating And Detecting Exosomal Biomarkers of Glioblastoma Malignancy
In this invention, atomic force microscopy (AFM) and localized surface plasmon resonance (LSPR) biosensors have been applied to prove the detection feasibility of GBM-derived exosomal biomarkers CD 44 and CD133 in vivo.
Prof. LEE Youngjin, Dr. THAKUR Abhimanyu, Miss LI Wing Kar
- Glioblastoma
- Exosomes
- CD44 and CD133
- Lactate
- AFM
- LSPR Biosensors
- Central nervous system
- Liquid biopsy
- Malignant glioma progression
- Diagnosis and prognosis